Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024

2d ago

CGEM

PremiumCompany Announcements

Cullinan Management’s Strategic Shift and Capital Raise

11d ago

CGEM

PremiumPress Releases

Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases

11d ago

CGEM

PremiumCompany Announcements

Cullinan Management’s Capital Dilemma: Balancing Equity, Debt, and Partnerships to Avoid Dilution and Restrictions

1M ago

CGEM

PremiumPress Releases

Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

1M ago

CGEM

PremiumPre-Earnings

CGEM Upcoming Earnings Report: What to Expect?

2M ago

CGEM

$Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for Novel MICA/B Antibody, CLN-619, for Relapsed/Refractory Multiple Myeloma$

PremiumPress Releases

Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for Novel MICA/B Antibody, CLN-619, for Relapsed/Refractory Multiple Myeloma

2M ago

CGEM

More CGEM News >

CGEM News on the Web

2024-04-24

Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday?

Yahoo Finance

Neutral

2024-04-24

Yahoo Finance

Neutral

2024-04-18

Strategic Shift and Promising Data Underpin Buy Rating for Cullinan Management’s CLN-978

TipRanks News

Bullish

2024-04-16

Cullinan Shifts Focus From Oncology To Autoimmune Disorders, Raises $280M Via Equity

Yahoo Finance

Neutral

2024-04-16

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cullinan Management (CGEM), Johnson & Johnson (JNJ) and UnitedHealth (UNH)

TipRanks News

Neutral

2024-04-16

Cullinan Management’s Promising Clinical Developments and Financial Prospects Warrant a Buy Rating

TipRanks News

Bullish

2024-04-16

Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases

Yahoo Finance

Neutral

2024-04-16

Cullinan Therapeutics Announces Oversubscribed $280 million Private Placement

Yahoo Finance

Neutral

News Score - Last 7 Days

Neutral

CGEM

Sector Average

Media Buzz

This Week2 articles

Weekly Average2.25 articles

News Sentiment

This Week50%

Sector Average59%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CGEM’s Media Buzz Sentiment?

2 articles about CGEM were published this week. In an average week, 2.25 articles are published.

What is CGEM’s weekly average amount of articles?

In an average week, 2.25 articles about CGEM are published.

What is CGEM’s News Sentiment?

50% of articles about CGEM were positive this week, compared to its sector average of 59%.

Healthcare Stocks that are Trending in the News

DAWNDay One Biopharmaceuticals

RMDResmed

TAKTakeda Pharmaceutical Company

IMVTImmunovant

NBIXNeurocrine

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing